. In addition to revitalizing other aged tissues [9] [10] [11] [12] [13] , exposure to factors in young blood counteracts age-related changes in these central nervous system parameters 14-16 , although the identities of specific cognition-promoting factors or whether such activity exists in human plasma remains unknown 17 . We hypothesized that plasma of an early developmental stage, namely umbilical cord plasma, provides a reservoir of such plasticity-promoting proteins. Here we show that human cord plasma treatment revitalizes the hippocampus and improves cognitive function in aged mice. Tissue inhibitor of metalloproteinases 2 (TIMP2), a blood-borne factor enriched in human cord plasma, young mouse plasma, and young mouse hippocampi, appears in the brain after systemic administration and increases synaptic plasticity and hippocampaldependent cognition in aged mice. Depletion experiments in aged mice revealed TIMP2 to be necessary for the cognitive benefits conferred by cord plasma. We find that systemic pools of TIMP2 are necessary for spatial memory in young mice, while treatment of brain slices with TIMP2 antibody prevents long-term potentiation, arguing for previously unknown roles for TIMP2 in normal hippocampal function. Our findings reveal that human cord plasma contains plasticity-enhancing proteins of high translational value for targeting ageing-or disease-associated hippocampal dysfunction.
, exposure to factors in young blood counteracts age-related changes in these central nervous system parameters [14] [15] [16] , although the identities of specific cognition-promoting factors or whether such activity exists in human plasma remains unknown 17 . We hypothesized that plasma of an early developmental stage, namely umbilical cord plasma, provides a reservoir of such plasticity-promoting proteins. Here we show that human cord plasma treatment revitalizes the hippocampus and improves cognitive function in aged mice. Tissue inhibitor of metalloproteinases 2 (TIMP2), a blood-borne factor enriched in human cord plasma, young mouse plasma, and young mouse hippocampi, appears in the brain after systemic administration and increases synaptic plasticity and hippocampaldependent cognition in aged mice. Depletion experiments in aged mice revealed TIMP2 to be necessary for the cognitive benefits conferred by cord plasma. We find that systemic pools of TIMP2 are necessary for spatial memory in young mice, while treatment of brain slices with TIMP2 antibody prevents long-term potentiation, arguing for previously unknown roles for TIMP2 in normal hippocampal function. Our findings reveal that human cord plasma contains plasticity-enhancing proteins of high translational value for targeting ageing-or disease-associated hippocampal dysfunction.
To begin to characterize differences in plasma proteins during different periods of life, we measured 66 common proteins in blood plasma from elderly individuals (aged 61-82 years), young adults (aged 19-24 years), and umbilical cord plasma from neonates (Extended Data  Fig. 1a ). Unsupervised clustering revealed distinct separation by age group in plasma proteins (Extended Data Fig. 1b) . Proteins expected to be elevated in cord plasma, including human chorionic gonadotropin-β and α -fetoprotein, were increased (Extended Data Fig. 1c, d ), and we detected age-related increases in immunoglobulin M (Extended Data  Fig. 1e ). To assess whether human plasma alters the hippocampus, a brain region critical for memory and influenced by young blood 15, 16 , we used immunodeficient 'NOD/SCID' (NSG) mice that could receive intravenous infusions of human plasma without adverse immune consequences 18 . Immunohistochemical comparison of hippocampi from young and aged NSG mice revealed reduced activation of the synaptic plasticity marker c-Fos, impaired neurogenesis, and increased microgliosis with age (Extended Data Fig. 2a-f) , consistent with observations in wild-type (WT) mice 15, 16, 19 . Compared with young NSG mice, aged mice exhibited impaired hippocampal-dependent learning and memory performance (Extended Data Fig. 2g -l) in modified Barnes maze 20 and contextual fear-conditioning tests; these differences were unrelated to pain, visual, and auditory sensory function (Extended Data Fig. 2m-p) . Thus, NSG mice exhibit typical age-related hippocampal dysfunction observed in WT mice by Barnes maze (Extended Data Fig. 2q , r) and fear-conditioning 15 , seemingly at an earlier age. To assess whether human cord plasma revitalizes aspects of brain function, plasma pools were created from cord, young adult, and elderly donors and injected intravenously into aged NSG mice every fourth day for 2 weeks before dissection of hippocampi for analyses (Fig. 1a) . Whole-genome microarray analysis revealed transcriptional profiles from hippocampi that distinctly clustered by intravenous treatment (Fig. 1b) ; the groups separated across the first three principal components, explaining the most gene expression variance (Fig. 1c) . Ontology-based comparison analysis of differentially expressed genes in human plasma-or vehicle-treated hippocampi suggested increased long-term potentiation (LTP) as a result of cord (Z-score = 2.12; P = 2.68 × 10 −2 ) or young (Z-score = 0.96; P = 2.59 × 10 −3 ) treatment, but not elderly (P > 0.05) plasma treatment. An additional predicted disease and functional pathway was memory (Z-score = 1.38; P = 2.61 × 10 −2 ), although only as a result of cord plasma treatment. The immediate early gene (IEG) cFos (also known as Fos) was among the top three most significantly increased genes resulting from cord plasma treatment, suggesting a possible re-activation of genes linked to memory consolidation 1, 21, 22 . To confirm the induction of IEGs and other genes linked to plasticity and memory, we measured gene expression by quantitative (q)PCR in dissected hippocampi from treated mice, finding that cord plasma treatment significantly increased expression of Egr1, Junb, Camk2a, Bdnf, Ntf3, Ppp3ca, cFos, and Nptx2, a late-response c-Fos/Junb target gene 22 ( Fig. 1d) . Notably, young adult human plasma treatment increased expression in a smaller subset of these genes, while elderly plasma did not lead to significant changes (Extended Data Fig. 3a, b) . At the protein level, only cord plasma treatment significantly increased the number of c-Fos-expressing cells within aged dentate gyrus ( Fig. 1e and Extended Data Fig. 3c ). The activation seemed to depend on context, since the pattern was not observed in other regions, including amygdala and motor cortex (Extended Data Fig. 3d , e), nor was it observed in young hippocampi (Fig. 1f) . Human plasma treatments did not alter phosphorylated cyclic AMP responsive element-binding protein (CREB) 16 or hippocampal neurogenesis (Extended Data Fig. 3f-i ), possibly because neural stem cells are depleted in the aged NSG brain. We next used the targeted recombination in active populations . Three days after a single injection of cord plasma, significantly more c-Fos-TRAPed cells were detected in the dentate gyrus and CA1 subfield (Fig. 1g-i and Extended Data Fig. 3j, k) , but not other regions (Extended Data Fig. 3l, m) , compared with control-injected mice. These results suggest cord plasma activates neuronal activity in the context of a functional immune system.
Given that dentate gyrus cells activated by cord plasma were granule-cell excitatory neurons 24 (Extended Data Fig. 4a-e) , and that neuronal c-Fos induction is important for synaptic plasticity underlying learning and memory 2, 21, 22 , we measured LTP in hippocampal slices from a separate cohort of aged NSG mice treated with cord plasma or vehicle. Extracellular recordings in dentate gyrus synapses revealed that cord plasma treatments significantly increased LTP compared with vehicle ( Fig. 2a-c) , although synaptic strength and paired-pulse facilitation were unaffected (Extended Data Fig. 5a-c) , suggesting a postsynaptic mechanism. The effect on LTP was not observed in slices from young NSG mice treated with cord plasma (Extended Data Fig. 5d-f ). Neither elderly nor young plasma treatment in aged NSG mice significantly affected LTP, although the latter treatment produced a trend towards increased LTP (Extended Data Fig. 5g-i) . To corroborate improvements observed in cognition-linked molecular and cellular plasticity parameters, we subjected separate cohorts of treated aged mice to Barnes maze and fear-conditioning testing. Cord-plasma-treated aged NSG mice reached the escape hole with b, Heat map of unsupervised clustering of gene changes in hippocampi following human plasma treatment of aged NSG mice (n = 7 per group; 13.8 ± 0.2 months old; colour bar represents Z-score range; one-way analysis of variance (ANOVA); P < 0.05). c, Three-dimensional plot of the first three components from PCA of whole-genome microarrays (WGM); inset graph represents eigenvalues (y axis) plotted against component number (x axis). d, Relative gene expression by qPCR for confirmatory plasticity genes after vehicle or human cord plasma treatment (n = 7 per group; 13.9 ± 0.2 months old). e, f, c-Fos-positive cell number in dentate gyrus (DG) of human-plasma-treated aged (e; n = 8, 7, 7, 7 mice per group (left to right); 13.9 ± 0.2 months old) or young (f) NSG mice (n = 8 mice per group; 3.4 ± 0.1 months old). g, Representative dentate gyrus and CA1 images and (h, i) recombined cell quantification (red; TdTomato) with counterstain (green; TO-PRO-3) from treated TRAP-FOS mice (n = 4, 3, 4 mice per group (left to right); 8-9.5 months old; scale bar, 100 μ m). One-way ANOVA with Tukey's post hoc test; Student's t-test for two-group comparisons; * P < 0.05, * * P < 0.01, #P = 0.05; mean ± s.e.m. , Population spike amplitudes recorded in dentate gyrus granule cell layer by perforant path stimulation with representative traces before LTP induction (a/a′ ) and after LTP maintenance (b/b′ ) (n = 11-12 slices per group (see Source Data for range details) from n = 5 NSG mice per group; eight intravenous injections; 11.7 ± 0.2 months old). c, LTP maintenance-phase quantification. d, Days 1-4 escape latency and (e) fourth-day acquisition rate of cord-plasma-treated (n = 8) or vehicletreated (n = 7) NSG mice in Barnes maze (eight intravenous injections; 12.9 ± 0.2 months old); T, trial. f, Contextual fear-conditioning freezing levels in separate cohort of cord-plasma-treated (n = 7) or vehicle-treated (n = 9) NSG mice (eight intravenous injections; 12.8 ± 0.2 months old). Two-way repeated-measures ANOVA with Bonferroni's post hoc test for time × group comparisons; Student's t-test for two-group comparisons. * P < 0.05, * * P < 0.01, * * * P < 0.001; mean ± s.e.m.
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shorter latency on the final testing day compared with vehicle-treated mice (Fig. 2d) , and their acquisition rate was faster (Fig. 2e) . Moreover, despite no differences in baseline freezing or cued freezing (Extended Data Fig. 5j, k) , freezing levels during the hippocampal-dependent contextual memory task were significantly higher in cord-plasma-treated mice (Fig. 2f) . Together, these results are consistent with predicted cord-plasma-mediated LTP and memory activations from ontologybased analysis of whole-genome microarrays.
Since cord plasma appeared to possess potent plasticity-promoting factors, we examined relative plasma protein changes in human donor groups and compared them with those in mouse plasma. We used customized discovery protein microarrays to detect several hundred plasma proteins of diverse functional classes (Supplementary Table 1 ). Unsupervised hierarchical clustering revealed age-dependent separation of changes in human and mouse plasma proteins (Fig. 3a) . We thus created a youth-associated protein list by overlapping human and mouse age-related plasma changes and by examining changes in aged mice after sharing young blood via parabiosis 16 (Extended Data  Fig. 6a ). We treated aged C57Bl/6 (WT) mice systemically with recombinant versions of several top candidate proteins. Treatment with CSF2 and TIMP2, but not GAS6, increased c-Fos activation in the dentate gyrus (Fig. 3b) . Cord-plasma-enriched CSF2 improved hippocampaldependent memory in aged mice (Extended Data Fig. 6b-k) , consistent with previous work in aged mice that develop Alzheimer's disease pathology 25 and validating our screening approach. Given the unexplored role of TIMP2 in CNS plasticity and cognition, we further pursued TIMP2 and confirmed elevations in cord plasma by enzymelinked immunosorbent assay (ELISA) (Fig. 3c ). Elevations were also observed between 7-to 8-week-old and 20-month-old mouse plasma by immunoblotting-differences that were larger between very young (1-month-old) and 20-month-old mice (Fig. 3d , e and Extended Data Fig. 7a, b) . Importantly, the 21-to 22-kDa TIMP2 band was absent in young TIMP2 knockout (KO) plasma (Fig. 3d) . We detected an agerelated decline in TIMP2 protein in hippocampal lysates by immunoblotting (Extended Data Fig. 7c, d ). Using confocal microscopy to further dissect changes in hippocampal TIMP2, we again found an age-related decline in TIMP2, most strikingly in neurons of the subgranular zone and hilar areas of dentate gyrus using a TIMP2 antibody validated in knockout sections ( Fig. 3f and Extended Data Fig. 7e-h ). The decline in TIMP2 may be related not to changes in overall intensity but rather to a gradual age-related loss of neurons within this subregion (Extended Data Fig. 7i, j) .
Using doses of 25-100 μ g kg
, we injected aged WT mice once or four times and examined c-Fos expression. Four TIMP2 injections every other day at 50 μ g kg −1 were needed to elicit significant c-Fos activation (Extended Data Fig. 7k, l) . 64 Cu-radiolabelled TIMP2 injected at this dose was detected in brain at significantly higher levels than albumin control and persisted 24 h after injection, while blood TIMP2 levels declined (Fig. 3g, h and Extended Data Fig. 7m, n) . Importantly, high-performance liquid chromatography in brain lysates of injected mice revealed a single radiolabelled species corresponding to the elution profile of intact TIMP2 before injection (Extended Data Fig. 7p, q) . Autoradiography revealed substantial entry into ventricular spaces approximately 24 h after 64 Cu-labelled TIMP2 injection, as well as signal in parenchyma, albeit to a lesser extent (Extended Data Fig. 7o ). To assess whether 50 μ g kg −1 TIMP2 activates c-Fos under conditions of physiological neuronal activity, we allowed mice to explore an enriched, novel environment. Enriched arena exploration alone activated c-Fos in dentate gyrus relative to normal housing conditions (Fig. 3i) , but arena-enriched mice also treated with TIMP2 exhibited a potentiated c-Fos response, suggesting that systemic TIMP2 activates plasticity under conditions of normal hippocampal function.
To investigate whether systemic TIMP2 was sufficient to improve hippocampal-dependent learning and memory, we administered TIMP2 over 2 weeks, leading to significant improvements in several functional outcomes (Extended Data Fig. 7r and Fig. 4a-f ). TIMP2 Letter reSeArCH treatment significantly improved the ability of aged WT mice to find the escape hole in the Barnes maze, while also enhancing acquisition rate (Fig. 4a, b) . Contextual memory was significantly enhanced in aged mice after TIMP2 treatment (Fig. 4c) , while baseline and cued freezing levels were unchanged (Extended Data Fig. 7s, t) . Moreover, TIMP2 treatment significantly restored nesting ability (Fig. 4d) , a behaviour strongly impaired in aged mice 26 . To examine whether TIMP2 altered plasticity on a synaptic level within the dentate gyrus, and in the absence of neurogenesis enhancements (Extended Data Fig. 8a, b) , we again treated aged WT mice with TIMP2 and measured LTP from dentate gyrus synapses in slices. LTP was robustly increased in mice treated systemically with TIMP2 (Fig. 4e , f and Extended Data Fig. 8c ), consistent with the learning and memory improvements observed. Conversely, LTP was significantly impaired in slices from TIMP2 KO mice compared with that measured from WT slices (Extended Data Fig. 8d , e). Young hippocampal slices incubated with anti-TIMP2 immunoglobulin-G (IgG) to target pools of brain TIMP2 exhibited markedly less LTP than control slices (Fig. 4g, h ), arguing that locally acting TIMP2 is important for activity-dependent synaptic plasticity. Notably, this decrease in LTP was not observed after treatment of TIMP2 KO slices with control or anti-TIMP2 IgG (Extended Data Fig. 8f, g ).
Given the age-related reduction of hippocampal TIMP2 expression and possible brain entry of TIMP2 after systemic treatment, we next assessed the necessity of blood-borne TIMP2 for hippocampaldependent memory. We used novel location recognition, a spatial, hippocampal-dependent task that also avoids reliance on startle response behaviour (Extended Data Fig. 9a , b) and motor coordination perturbed with loss of TIMP2 function 27, 28 . Young WT mice were given systemic injections of TIMP2 neutralization or control antibody for 4 weeks before novel location recognition testing. Antibody treatments did not alter overall metabolism, organ function, or weight gain (Extended Data Fig. 9c, d ). Neither anxiety-linked open-field behaviour nor overall activity was altered by treatment (Extended Data Fig. 9e-i ), which was verified in an independent activity task (Extended Data Fig. 9j-m) . While neurogenesis was unaltered (Extended Data Fig. 9n , o), mice in which systemic TIMP2 had been targeted by TIMP2 antibody completely lost preference for the displaced object 1 day after training (Fig. 4i) , suggesting a critical role of TIMP2 in spatial memory. Many immune and trophic factors were significantly upregulated in plasma from TIMP2 KO mice (Extended Data Fig. 10a ), suggesting that TIMP2 may be a critical regulator in the systemic proteome and perhaps the systemic-CNS communicome. e, f, Population spike amplitudes recorded in dentate gyrus granule cell layer following perforant path stimulation (e) and maintenance-phase LTP quantification (f; n = 10 slices per group from n = 5 mice per group; eight intravenous injections of vehicle or TIMP2; 20-month-old). g, h, PSA recorded in dentate gyrus granule cell layer following perforant path stimulation in slices incubated with indicated ex vivo treatments (g) and maintenance-phase LTP quantification (h; n = 10 slices per group from n = 7, 4, 5 WT mice per group (left to right); 2-month-old mice).
i, Discrimination for novel object displacement on day 2 for young WT mice treated every other day for 4 weeks with anti-TIMP2 IgG or control IgG (n = 15 per group; 2.5-month-old). j-l, Latency to escape hole in Barnes maze (j), day 4 acquisition rate (k), and contextual fear-conditioning freezing levels (l) in aged NSG mice (13.8 ± 0.1 months old) given eight intravenous injections of vehicle (n = 10), TIMP2-depleted cord plasma (n = 8), or IgG control-depleted cord plasma (n = 9) (in j, * and † indicate control-depleted cord plasma versus either vehicle or TIMP2-depleted cord plasma groups, respectively). One-way ANOVA with Tukey's post hoc test for h, k, l; two-way repeated-measures ANOVA with Bonferroni's post hoc test for a, j; Student's t-test for two-group comparisons; χ 2 analysis for d; two-way ANOVA with Tukey's post hoc test for i; * P < 0.05, #P = 0.05, * * P < 0.01, † † † or * * * P < 0.001, * * * * P < 0.0001; mean ± s.e.m. To assess the necessity of TIMP2 in mediating cognitive improvements caused by cord plasma treatment, we first efficiently immunodepleted (> 99%; Extended Data Fig. 10b ) human TIMP2 from cord plasma without grossly depleting other proteins compared with control depletion (Extended Data Fig. 10c ). After treatment of aged NSG mice with vehicle, control-depleted or TIMP2-depleted cord plasma, Barnes maze (Fig. 4j, k) and contextual fear-conditioning (Fig. 4l) assessments revealed a striking dependency on TIMP2 and its putative cofactors for the previously observed cognitive benefits conferred by cord plasma, especially in the Barnes maze. Other behavioural measures were unable to account for the cognitive differences among groups given the lack of differences in baseline and cued fear-conditioning freezing, open-field behaviour, and various activity measures (Extended Data Fig. 10d-m) .
The necessity of TIMP2 for the beneficial activity of cord plasma and its ability to improve aspects of hippocampal function at an age when TIMP2 expression has declined suggest that it may be a critical mediator in mechanisms governing synaptic plasticity. Future studies should dissect the putative cellular targets of TIMP2 produced within the hilus and the extent to which these signals impinge on local circuitry to regulate activity of synapses throughout the hippocampus. Given the many potential targets in the brain, TIMP2 may exert its effects on plasticity through complex interactions with matrix metalloproteinases and integrins to regulate extracellular matrix and structural protein turnover 29 . Together, our results argue that systemic factors present early in life may be beneficial for revitalization of aged tissue and that TIMP2, a protein enriched during development 30 , represents such a restorative factor for the aged hippocampus.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. ) mouse model 23 to examine c-Fos activation following neonatal plasma treatment. TRAP-FOS mice on a C57Bl/6J background were given a single intravenous injection of human plasma or vehicle (175 μ l), followed 2 h later by intraperitoneal injection of the tamoxifen derivative 4-hydroxytamoxifen (4-OHT; 50 mg per kg; freshly prepared). Seventy-two hours after injection of 4-OHT, mice were euthanized for immunohistochemical analysis. Parabiosis. Heterochronic parabiotic pairs consisting of aged and young mice (18-month-old with 3-month-old) or isochronic pairs consisting of aged mice (18-month-old with 18-month-old) were connected according to previously described methods 9, 16, 31 . Briefly, under aseptic conditions and continuous isoflurane anaesthesia, mirror-image incisions at left and right flanks were made through the skin with smaller incisions through the peritoneal cavity. Adjacent peritoneal cavities were sutured together continuously and closed. Knee and elbow joints from adjacent mice were sutured together to facilitate coordinated locomotion during recovery to minimize distress. Skin was stapled together using surgical autoclips (9-mm, Clay Adams). Surgeries were performed on heating pads and body temperature was monitored throughout the procedure. Mice in each pair were injected subcutaneously with Baytril antibiotic (5 μ g per g) and buprenorphine (0.05-0.1 μ g ml ) for pain management and 0.9% (w/v) NaCl for hydration. Pairs were monitored continuously for signs of distress according to recovery parameters characterized in previous work 31 . Human and mouse plasma collection and injections. Cord (live umbilical venous collection at birth), young, and elderly blood was collected for the isolation of ethylenediaminetetraacetate (EDTA)-plasma under Stanford Institutional Review Board consent and approval. Young (median = 22 years) and elderly (median = 66 years) healthy subjects were male and predominantly caucasian; elderly subjects were cognitively normal according to neurological examination. Isolated plasma was stored in aliquots at − 80 °C until analysis or before pooling and dialysis to remove EDTA for treatment experiments where indicated. Intravenous injections of human plasma (175 μ l) were administered six times for staining/qPCR experiments and eight times for behavioural and LTP experiments, with 2 days between each injection. Under 3.8% (w/v) chloral hydrate or 2.5% (v/v) avertin anaesthesia, mouse blood was collected with EDTA as anticoagulant by terminal intracardial bleeding. EDTA-plasma was isolated by centrifugation at 1,000g for 10 min at 4 °C before aliquoting and storage at − 80 °C before analysis. In the anti-TIMP2 IgG-or control IgG-treated cohort of mice monitored for signs of toxicity, serum was collected at the conclusion of behavioural assessments. Under 2.5% avertin anaesthesia, blood was drawn by intracardial bleeding, allowed to clot for 45 min at room temperature, and then serum was collected by centrifugation at 2,000g for 10 min at 4 °C. Serum was submitted for measurement of electrolytes and other measures of organ function by the Animal Diagnostic Laboratory at Stanford Veterinary Service Center. One sample from each group was found to be haemolysed and thus not submitted to avoid confounding haemolysis-sensitive assays. Plasma protein measurement. Luminex-based detection, ELISA, western blotting. Quantitative measurements for 66 detectable plasma biomarkers in Extended Data Fig. 1 were made by fee-for-service (Myriad RBM) using the multiplexed HumanMAP version 2.0 platform; two-way hierarchical clustering analysis was performed using Cluster 3.0 using correlation similarity metric distance. Left-censored values below detection were replaced with half the detection limit. Quantitative validation for candidate factors from customized protein microarray results identified from overlap analysis was done with commercially available ELISAs for CSF2 (human V-Plex, Meso Scale Diagnostics) and TIMP2 (human Quantikine, R&D Systems) according to the manufacturer's specifications. Equivalent volumes of plasma (2 μ l) were loaded onto 4-12% bis-tris gels for SDS-polyacrylamide gel electrophoresis before transferring to nitrocellulose membranes for immunodetection of mouse TIMP2 (1:500; Rabbit mAb; Cell Signaling, D18B7). For hippocampal western blotting of TIMP2, dissected hippocampi were manually dounce-homogenized with 60 strokes in radioimmunoprecipitation assay buffer with protease inhibitors and briefly sonicated (5 s, three times, 15% amplitude; Branson Ultrasonics) before centrifugation at 20,000g for 25 min at 4 °C. Immunoblotting for TIMP2 was performed as described above, and neuron-specific enolase was immunoblotted for loading normalization (1:5,000; Mouse IgG; Thermo, 5E2). Band intensities were quantified using ImageJ software as described 32 . Protein microarrays. Customized mouse or human versions of protein microarrays were created, as described 33 , solely as a discovery platform with which to identify promising hits that could be validated by subsequent, more quantitative assays. Specifically, ELISA-grade antibodies against several hundred secreted and potentially cleaved transmembrane mouse or human signalling proteins were obtained from commercial sources and printed in five replicates onto SuperEpoxy2 glass slides (Arrayit) with a robotic microarrayer (NanoPrint LM210, Arrayit) fitted with 16 946MP4B pins. Arrays were vacuum-sealed and stored at 4 °C until use. Before labelling with biotin, human or mouse plasma samples were diluted and dialysed (96-well Dispodialyzer, 5-kDa molecular weight cut-off, Harvard Apparatus), exchanging PBS (pH 6.5 for mouse and pH 8.0 for human arrays) multiple times at 4 °C. Samples were then biotinylated on primary amino groups (EZ-link NHSBiotin, Thermo-Scientific) overnight at 4 °C, and unbound biotin was removed by PBS dialysis. Arrays were then blocked with 3% (w/v) casein solution before incubation with the individual biotinylated samples overnight at 4 °C. Following washes, arrays were incubated with Alexa Fluor 555-conjugated streptavidin secondary antibodies (Life Technologies) for detection of the fluorescent signals using a GenePix4400A scanner and GenePix Pro7 software (Molecular Devices). A complete list (HUGO Gene Nomenclature Committee official gene names) of all unique proteins we sought to detect with arrays for the generation of candidates is provided in Supplementary Table 1 . Protein microarray data processing and analysis. Background for fluorescent signals of individual array spots was subtracted and raw data average intensities were calculated from five replicates per antibody. Antibodies with insufficient signal to noise were filtered out. Negative values were imputed and replaced by 50% of the lowest values detected for a given antibody's signal. Log-transformation and iterative row-and column-wise median centering and normalization were performed using Cluster 3.0 (ref. 34) or log-transformed following a Shapiro-Wilk test to assess normality (P < 0.05). Z-scored values were used for unsupervised, array by protein cluster analysis before heat map visualization using Java TreeView 1.0.13 (ref. 35 ) on the basis of d-score rankings from SAM 3.0 algorithm 36 . Relative protein expression levels correlated with ageing or significantly different between aged isochronic and aged heterochronic plasma were determined by SAM. d-scores were assigned to each protein on the basis of multi-comparison analysis of expression changes across arrays. To generate a list of candidate proteins that might improve plasticity in aged mice, d-scores from SAM were used to rank proteins that declined with age in the mouse array, and a composite meta-ranking was made by comparing this to the d-scored proteins that declined in the human array (from cord to elderly). A list was created in the same way to capture cordplasma-enriched proteins also elevated in the plasma of aged heterochronic mice (sharing young blood) versus aged-isochronic parabiont plasma. Extended Data Fig. 6a reflects sequential sorting by q value and d-score of the list. For limited in vivo screens, TIMP2, CSF2, and GAS6 were chosen from this list on the basis of literature review and availability of suitable recombinant protein. Pre-and postsurgery plasma from parabionts was also collected for comparison of changes, in addition to examining young and aged isochronic plasma protein changes for validation.
For subsequent mouse plasma experiments to examine relative protein abundance in TIMP2 KO versus WT mouse plasma (Extended Data Fig. 10a ), mouse protein arrays were printed and run as described for earlier arrays; multiple steps of filtering of the raw data were performed on the basis of antibody performance before normalization during further optimization of the platform. Briefly, antibodies with low signal, large coefficient of variation across five replicate spots, or those with high coefficients of variation across four identical biological replicates (four random subjects run in four identical repeats) were filtered out. Nondetectable values were imputed and replaced by 50% of the lowest value detected for a given antibody. Each signal was normalized by the median of all signals on one array, followed by log-transformation after assessing normality (Shapiro-Wilk test, P < 0.05) and then Z-scoring across all arrays. After filtering, 123 antibodies were used for differential expression analysis. Student's t-test (α = 0.05) was performed to compare differences between two groups with q < 0.15. Extracellular electrophysiology. After eight systemic injections of the indicated human plasma versus vehicle (PBS) in either young or aged NSG mice or rTIMP2 (50 μ g kg
) versus vehicle in aged WT mice, deep anaesthesia was induced with isoflurane before mice were euthanized. Brains were removed and placed in icechilled artificial cerebrospinal fluid (in mM: NaCl 124.0, KCl 2.5, KH 2 PO 4 1.2, CaCl 2 2.4, MgSO 4 1.3, NaHCO 3 26.0 and glucose 10.0 (pH 7.4)) that was continuously bubbled with 5% CO 2 /95% O 2 . Hippocampal slices (400 μ m) were prepared using a tissue chopper (Stoelting) and incubated in continuously oxygenated artificial cerebrospinal fluid for at least 1 h before recording with continuous 5% CO 2 /95% O 2 bubbling. Data were collected using an Axopatch-2B amplifier and pClamp 10.4 software (Axon Instruments). Slices were in submerged mode at room temperature, continuously perfused with oxygenated artificial cerebrospinal fluid at a flow rate of 2 ml min −1 using a peristaltic pump (Haake Buchler). Population spikes were recorded in the granule cell layer of the dentate gyrus with glass microelectrodes (resistance 1-3 MΩ). Stimulation of the perforant path with biphasic current pulses (0.2 ms duration for one phase, 0.4 ms in total) was delivered in intervals of 10 s through a bipolar, concentric stimulating electrode (FHC). Using this frequency stimulation protocol, no obvious synaptic depression or facilitation was observed. Slices were recorded within 8 h of dissection. Signals were digitized at 20 kHz, and a Gaussian low-pass filter was applied as needed to reduce noise. Input-output curves were constructed for each slice using stimulus intensity from threshold to 1.0 mA. Test pulse intensities were adjusted to evoke field potential to approximately 35-50% of maximal input-output response. Tetanic stimulation was executed with two trains of 100 pulses (0.4 ms pulse duration, 100 Hz) delivered with an inter-train interval of 5 s. Amplitudes of population spikes were measured from the initial phase of the negative wave with Clampfit 10.4. LTP was plotted as the percentage of baseline just before tetanic stimulation (mean ± s.e.m.) and the graph scaled to reflect effects in the maintenance phase (first one or two points after baseline could be outside scale). The maintenance phase was quantified over the final 6 min (39.5-45.5 min) of the LTP experiment. Paired-pulse ratios were measured with various inter-pulse intervals (20 ms, 50 ms, 100 ms). Paired-pulse ratio was calculated before or after LTP as the percentage of the amplitude of the second response minus the first response divided by the value of the first response. In rare cases, values were not obtained at all time points owing to experimental or equipment error. Data were processed and analysed with pClamp 10.4, Microsoft Excel, and StatView 5.0.
For experiments in which isolated slices from young WT (C57Bl/6J) or TIMP2 KO mice were assessed, or for those in which slices were incubated with vehicle (PBS), control IgG (R&D) or anti-TIMP2 IgG (R&D, AF971), LTP was performed in essentially the same fashion but with minor differences. Briefly, tetanic stimulation consisted of one train of 100 pulses (0.4 ms pulse duration, 100 Hz) since preliminary experiments revealed that two trains of high-frequency stimulation in younger slices tended to create short-term depression of field potentials in dentate gyrus, lasting approximately 10 min. For experiments involving bath incubation of the isolated slices, we adapted a previously described method for antibody blocking experiments in the context of LTP 37, 38 . Slices were incubated with fresh control IgG (R&D Systems) or anti-TIMP2 IgG (R&D Systems) at 4 μ g ml −1 in a clean chamber for ~ 2 h (1.8 ± 0.2 h, IgG control; and 1.9 ± 0.3 h, anti-TIMP2 IgG) at room temperature before transferring to recording chamber. Antibodies or vehicle were perfused continuously through a closed loop during recording through silicon tubing (VWR) (with the exception of a 5-cm portion connected to the pump). BSA was omitted from perfusion to minimize bubbling; efforts were taken to minimize bubbling of artificial cerebrospinal fluid in the perfusion system that would perturb oxygen and pH consistency. Recombinant protein injections. Recombinant mouse TIMP2 (R&D Systems) or CSF2 (Sino Biological) proteins were resuspended in physiological buffer, aliquoted and stored at − 80 °C for single-injection use at 50 μ g kg . Mice were given systemic injections (intraperitoneal) of vehicle or recombinant protein every other day at frequency and durations indicated in the respective figure legends. Plasma TIMP2 immunodepletion. To remove TIMP2 present in human umbilical cord plasma, anti-TIMP2 IgG (R&D) or goat control IgG (R&D) were efficiently conjugated to 2.8-μ m superparamagnetic M-270 Epoxy dynabeads according to the manufacturer's instructions (ThermoFisher) using a coupling ratio of 5 μ g of antibody per 1 mg of beads for 24-h covalent conjugation at 37 °C with end-overend rotation. Steps were taken to minimize detergent carryover in certain steps, for example substitution with PBS, in preparation for treatments in vivo. Freshly dialysed cord plasma from the collections of nine individuals was thawed, pooled, and divided into 500-μ l aliquots before incubation with prepared control IgG-bead or anti-TIMP2 IgG-bead solutions overnight at 4 °C. An aliquot of cord plasma without beads was carried through the procedure to verify no loss due to handling/ degradation. Isolated control IgG-depleted or anti-TIMP2 IgG-depleted plasma was frozen and stored in preparation for injections of aged NSG mice. Human TIMP2 ELISA on the pooled, depleted plasma revealed TIMP2 levels well below the detection limit of the assay compared with levels measured in cord plasma aliquot before depletion ('pre-depletion'), and no reduction was detected in control IgG-depleted plasma (Extended Data Fig. 10b ). Complete elution of the beads in denaturing/reducing conditions was performed, and the resulting elution was separated by SDS-polyacrylamide gel electrophoresis before silver staining according to standard methods. Briefly, gel was incubated in 10% acetic acid/50% methanol (fixation), sensitized in 2.5 mM sodium thiosulfate, silver stained in silver nitrate (12 mM), and developed in a solution of sodium carbonate (0.3 M), sodium thiosulfate (25 μ M), and formaldehyde (0.02% (w/w)). The silver-stained gel revealed a depletion pattern that was indistinguishable between the IgG control or anti-TIMP2 IgG depletion conditions (Extended Data Fig. 10c) . Mouse behavioural assays. A modified Barnes maze test was performed similarly to that previously described 20 , and tailored minimally to our strains of mice. Briefly, a large circular maze containing 40 holes was centred over a pedestal and elevated approximately 40 cm above the floor. The escape hole consisted of a long PVC elbow joint connector that was similar in texture and colour to the maze. Distinct visual cues were placed at four equally spaced points around the maze, as shown in Extended Data Fig. 2g . An overhead light provided additional motivation to find the escape hole. The task proceeded over a period of 4 days, with four trials on each day for each mouse. With overhead illumination and a persistent 2 kHz tone, mice were given 90 s for each trial to identify the escape hole by jumping in or identifying the hole with extended/overt head pokes. If mice failed to identify the escape hole within the allotted 90 s, they were gently guided by light tapping/ directing towards the escape hole and scored at the allotted investigation time. The escape hole position was fixed within a day but changed for each successive day of testing. For each trial within a day, the starting location for the mouse was rotated relative to the escape hole position. Between each trial, the maze and escape hole were thoroughly cleaned to remove any cues that might affect performance in subsequent trials.
Several sensory modalities were assessed in young and aged NSG mice. Pain sensitivity to the foot-shock apparatus used for fear-conditioning was assessed using the procedure described in ref. 39 . In this assay, each mouse was placed in the foot-shock chamber with a front-mounted camera to visualize various pain sensitivity parameters, which encompassed four clearly defined behaviours, as described 39, 40 : 'flinch' , 'run' , 'vocalization' , and 'two-paw jump' . One-second shocks of various intensities were delivered in the following order (in milliamps): 0.05, 0.08, 0.10, 0.13, 0.16, 0.20, 0.25, 0.30, 0.35, 0.40, 0.45, each spaced by 30 s of recovery time. Thresholds reflected the minimum shock intensity at which each behaviour was observed using the front-mounted camera video. To assess visual ability, the visual cliff task was adapted according to the classical method 41 , a task recently used to detect complex age-related visual deficits in models of neurodegeneration 42 as a means of validating spatially dependent cognitive assays. Briefly, a chamber was constructed with dimensions 60 cm × 60 cm × 30 cm using white plastic and a transparent (non-glare) bottom. The fabricated box was extended halfway across a table elevated 1 m above the floor. Chequered fabric served as the floor below the box, which then draped downwards, extending onto the floor to create the visual cliff illusion. A series of light sources illuminated the chamber interior to prevent dark retreat areas, and an additional light was directed towards the edge to accentuate the cliff illusion. Two trials were performed for each mouse; a stopwatch was used to score the time elapsed before stepping onto the 'cliff side' as well as the duration spent on the 'bench side' or 'cliff side' of the chamber in the 5-min period. The auditory startle response assay was used to assess auditory sensory processing (Kinder Scientific). Each mouse was placed in a non-restrictive, ventilated, sound-attenuated chamber atop a sensor platform. After a 5-min acclimation period inside the chamber, startle sensitivity to various audible pulses (80, 90, 100, 110, 120 dB) was recorded. Five trials of each sound intensity were performed for each mouse, and each trial was presented once in a random sequence within each test session block with a variable inter-trial interval of 12-30 s (15 s on average). Startle response amplitudes were recorded and analysed via software interface (StartleMonitor), and the maximum response to each sound stimulus across the five trials was considered the acoustic response. All trials were performed in the same apparatus to minimize system error across trials, and aged and young mice were tested in a randomized sequence. The apparatus was calibrated using a standard 100-g weight.
For enriched housing exploration experiments to examine c-Fos activation under conditions of physiological neuronal activity, aged WT mice were treated systemically with vehicle or rTIMP2 (50 μ g kg
) over a period of 1 week before a 10-min exposure to enriched housing (toy ball, tunnel, toy car, bell, blocks, wallmounted visual cues, etc.). After the exploration, mice in enriched housing were returned to home cages for 90 min before being euthanized.
In young WT mice that had been injected with 60 μ g kg −1 anti-TIMP2 antibody (R&D Systems, AF971; dose based on the in vitro ND 50 (50% neutralizing dose from the manufacturer) or goat control IgG (R&D Systems), novel location recognition was performed as previously described 43 . Briefly, on day 1 (training), Letter reSeArCH mice were first habituated to the open-field arena, which contained wall-mounted visual cues, for a period of 6 minutes. Mice were given three consecutive trials during which they explored two objects in fixed positions. On day 2, mice explored the same arena but with one object displaced. Investigative interactions with objects were manually scored in a blinded fashion to assess object discrimination: that is, percentage object discrimination = ((displaced object interaction time)/(total interaction time of both objects)) × 100.
To assess anxiety-like and general exploratory activity levels, an open-field assay was used in which mice were placed in an illuminated, novel arena for 360 s and allowed to explore. Open-field exploratory behaviour was analysed using TopScan Lite software (Cleversys), which divided the chamber into a centre zone, in which mice tended to exhibit anxiety-associated activity, and the floor zone, in which mice exhibited normal activity behaviour. The SMARTCage beam-break monitoring system was used to assess general measures of activity in a homecage-sized arena 31 , which allowed activity assessment independent of anxiety-like behaviours associated with open-field exploration. Briefly, mice were placed inside monitored home cages that were each lined with bedding and covered with a cage top. Measures of activity (overall activity, rearing activity, distance travelled, average velocity) were recorded and analysed using the CageCenter tracking software/ computer interface over the 360-s period of exploration.
Fear-conditioning experiments were performed as previously described 15, 16 . Briefly, mice were trained to associate the cage context with an aversive stimulus (light foot-shock), allowing us to measure freezing levels indicative of hippocampal-dependent memory. Our protocol for NSG (NOD/ShiLtJ background) and WT (C57Bl/6 background) mice differed slightly. For NSG mice, training parameters on day 1 were as follows: two periods of 30 s consisting of paired cue light and 1,000-Hz tone followed by 2 s foot-shock (0.7 mA) with a 180-s interval between. On day 2 of testing, NSG mice exhibited recall after 90 s in context and freezing levels were analysed for the subsequent 90 s. The cued task was performed by changing the cage context (fabricated inserts with novel texture, colour, and odorant). Mice were placed in the novel context and exposed to the same tone and cue light from day 1 (training) after 180 s of exploration. Freezing levels were analysed for the subsequent 90 s. Fear-conditioning training for WT mice on a C57Bl/6 background used the following parameters: two periods of 30 s consisting of paired cue light and 1,000-Hz tone followed by a 2-s foot-shock (0.6 mA) with a 180-s interval between. The following day, mice were re-exposed to the context where freezing levels (recall) were particularly striking for the last 120 s for TIMP2 treatment or the first 120 s with CSF2 treatment. For the cued task, mice were placed in a novel context and exposed to the same tone and cue light from day 1 (training) after 120 s of exploration. Freezing levels were analysed for the subsequent 90 s. All freezing levels were measured using a FreezeScan video tracking system (Cleversys). Owing to variation in baseline cognitive performance reported previously for aged WT (C57Bl/6 background) mice 43 and routinely observed in our experience, aged WT mice were exposed to novel location recognition testing, as previously described 43 , to score hippocampal-dependent memory performance. These values were used to divide mice equally into the two groups well before treatments and subsequent behavioural testing. After treatment of the equally stratified groups, blinded identification numbers were assigned to all mice, and the numbers were randomized for Barnes maze and fear-conditioning tests. Immunohistochemistry. Brain tissue processing, immunohistochemistry, and immunofluorescence experiments were performed as described previously 15, 16 . Briefly, mice were euthanized with 3.8% (w/v) chloral hydrate or 2.5% (v/v) Avertin and transcardially perfused with chilled 0.9% (w/v) saline or PBS. Brains were dissected and hemibrains were isolated for immunohistochemistry and postfixed in 4% (w/v) paraformaldehyde for 48 h at 4 °C before preservation in 30% (w/v) sucrose in PBS. Hemibrains were sectioned coronally at a thickness of 40 μ m on a freezing-sliding microtome, and sections were stored in cryoprotective medium at − 20 °C. Free-floating sections were blocked with appropriate serum before incubation at 4 °C with primary antibodies at the following concentrations for light microscopy: c-Fos, 1:10,000, PC38, Oncogene Research Products; doublecortin (DCX), 1:500, SC8066, Santa Cruz Biotech; CD68, 1:600, MCA1957, BioRad; pCREB, 06-519, 1:5,000, Millipore; and the following concentrations for confocal microscopy: c-Fos, 1:400, 9F6, Cell Signaling; Gad67, 1:2,000, MAB5406, Millipore; Prox1, 1:500, AF2727, R&D Systems; NeuN, 1:200, MAB377, Millipore; mCherry, 1:200, AB0040-200, Sicgen; TIMP2, 1:100 (two nights), AF971, R&D Systems; Iba1, 1:500, 019-19741, Wako; and TO-PRO-3, 1:1,000, T3605, Life Technologies. For light microscopy, staining was visualized by incubating sections with respective biotinylated secondary antibodies, followed by reaction with the ABC kit (Vector) and diaminobenzidine (DAB; Sigma) staining. Images of brain sections were acquired by automated slide scanner (Hamamatsu Photonics) or by conventional light microscopy. National Institutes of Health ImageJ software was used to quantify the percentage of hippocampal area covered by thresholded CD68 staining or mean intensity for pCREB. The number of DCX-positive cells within the dentate gyri was counted manually and the total estimated as described 15 for both hemispheres. The number of c-Fos-positive cells in dentate gyrus was determined in five regularly spaced sections from the rostral to caudal extent of the hippocampus and doubled to account for both hemispheres. Manual counts of the number of c-Fos-positive cells present in three regularly spaced sections of lateral/basolateral amygdala and retrosplenial/motor cortex were made starting at − 1.38 mm with respect to bregma in the mouse Scalable Brain Atlas 44, 45 . All counts were performed in a blinded fashion.
For immunofluorescence experiments, after incubation with fluorescently conjugated secondary antibodies, brain sections were mounted and coverslipped with ProLong Gold (Life Technologies) before imaging with a confocal laser-scanning microscope (Zeiss). Absolute counts of the number of c-Fos-positive cells (or FOSTRAPed cells) or co-stained cells were obtained through the entire z plane (~ 40 μ m) using five sections per mouse for hippocampus (rostral through caudal extent of dentate gyrus) or the procedure described above for lateral/basolateral amygdala and retrosplenial/motor cortex counts. Co-localization was assessed at 1 Airy unit for each laser. Tile-scanning was performed for representative images taken for TRAP-FOS mice to provide high-resolution images of large areas of CA1 and dentate gyrus. Four sections per mouse (rostral through caudal extent of dentate gyrus) were used to count TIMP2 + cells possessing NeuN + or NeuN − nuclei or TIMP2 + cells co-expressing Iba1 within the dentate gyrus (subgranular zone and hilar subregions) of the hippocampus through a 25.6-μ m z-stack acquired using a pinhole of 1 Airy unit for each laser. Optimization experiments revealed that TIMP2 KO sections were devoid of signal, validating the specificity of the TIMP2 antibody (Extended Data Fig. 7e ). TIMP2
+ cells in dentate gyrus/hilus were consistent with the localization pattern observed in bacterial artificial chromosome (BAC)-TIMP2-eGFP (enhanced green fluorescent protein) mice as part of the GENSAT Project's mouse brain expression atlas (http://www.gensat.org/ imagenavigator.jsp?imageID= 72836). Radiolabelled TIMP2 blood-to-brain tracer studies. DOTA conjugation. Conjugation of recombinant mouse TIMP2 (R&D) and BSA (Sigma) with 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) was performed according to standard published procedures using metal-free buffers 46, 47 . Briefly, a solution of DOTA-NHS ester (Macrocyclics) in dimethyl sulfoxide (25 mmol l , pH 8.8) containing 100 μ g of TIMP2 or BSA, and the reaction mixture was incubated at room temperature for 1 h. Excess DOTA-NHS was removed by Zeba Spin Desalting Columns (0.5 ml, 7K molecular weight cut-off, ThermoFisher Scientific), and the resulting solution was buffer-exchanged into ammonium acetate buffer (0.1 M, pH 5.5) for 64 Cu labelling. DOTA-conjugate solutions were concentrated by ultrafiltration (Vivaspin 0.5 ml, Sartorius) to 0.1-0.4 mg ml −1 and stored at 4 °C before radiolabelling. For TIMP2, all conjugation steps were performed < 6 h before radiolabelling, and the final DOTA-conjugated protein was kept on ice. The numbers of chelators coupled per TIMP2 or BSA were estimated to be 2 and 2.2 respectively, by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Radiolabelling. Radiolabelling of DOTA-TIMP2 and DOTA-BSA with 64 Cu (half-life = 12.7 h) was performed using standard methods with some modifications [46] [47] [48] Cu-labelled DOTA-BSA (2.50 ± 0.06 MBq). After 1, 3, or 24 h, groups of mice injected with each tracer were deeply anaesthetized with 2.5% (v/v) Avertin, and blood samples (100-200 μ l) were collected by cardiac puncture immediately before transcardial perfusion with ~ 30 ml chilled PBS. The brain was extracted from each mouse, placed in a tube for gamma counting, and weighed; satisfactory perfusions were verified by visual inspection of brain tissue. Tissue-associated radioactivity in blood and brain was assessed by an automated gamma counter (Cobra II AutoGamma counter; Packard Biosciences), normalized to tissue mass and to amount of radioactivity administered to each mouse, and decay-corrected to time of tracer injection using diluted aliquots of the initial administered dose as standards. Ex vivo autoradiography. At 24 h after injection of 64 Cu-labelled TIMP2 (7.57 ± 0.15 MBq), mice were deeply anaesthetized with 2.5% (v/v) Avertin and perfused with ~ 30 ml chilled PBS. Brain tissue was quickly embedded in optimal-cutting temperature compound (Tissue-Tek), and coronal or sagittal sections (20 μ m) were obtained for ex vivo autoradiography. Autoradiography was conducted using previously described methods 49 , confirming anatomical localization by Nissl staining (cresyl violet acetate; Sigma Aldrich) using standard techniques. In brief, sections of 20 μ m were mounted on microscope slides (Fisherbrand Superfrost Plus Microscope Slides), air-dried for 10 min, and then exposed to a digital storage phosphor screen (Perkin Elmer, USA) for 72 h at − 20 °C. The image plate was analysed using a Typhoon 9410 Variable Mode Imager (Amersham Biosciences, USA) and images were visualized and processed by ImageJ (image processing and analysis software in Java, version 1.45s). Metabolic stability studies. Stability of 64 Cu-labelled TIMP2 in mouse brain 24 h after intraperitoneal injection of radiotracer (19.27 ± 1.32 MBq) was determined as described previously 50 with minor modifications, including the use of a Bioscan Flow-Count radioactivity detector to enable sensitive detection of potential radiometabolites. Briefly, mice were deeply anaesthetized with 2.5% (v/v) Avertin, and perfused with chilled PBS (~ 30 ml) 24 h after intraperitoneal injection of 64 Cu-labelled TIMP2. Brain tissue was quickly collected and transferred to a tube containing 750 μ l ice-cold 70:30 methanol:sodium phosphate buffer (0.1 M, pH 6.8). Samples were homogenized using an Omni TH tissue homogenizer, and protein precipitates were sedimented by centrifugation (9,400g, 10 min). Each supernatant (100 μ l) was analysed via high-performance liquid chromatography (fitted with a highly sensitive positron detector for radioactivity) using size-exclusion liquid chromatography with a Phenomenex SEC 3000 column (Torrance, California, USA) and sodium phosphate buffer (0.1 mol l Cu-labelled TIMP2 (t R = 11.5 min) was calculated as (peak area for 64 Cu-labelled TIMP2/total area of all peaks) × 100. More than 95% of the radioactivity was recovered from the column for the analysed samples. qPCR and whole-genome microarrays. After rapid dissection of hippocampi, tissue was preserved in RNA-later (Ambion) at 4 °C before storing at − 80 °C until use. Hippocampal RNA was extracted according to the manufacturer's instructions using an RNeasy Mini Kit (Qiagen). Bioanalyzer (Agilent Technologies) quality control revealed high-quality RNA as assessed by RNA integrity number. Isolated RNA was used for transcription, labelling, and hybridization to wholegenome microarrays (Affymetrix, Mouse 2.0ST; with the assistance of Stanford Translational Applications Service Center/Protein and Nucleic Acid facilities) or to prepare cDNA with the RT 2 First Strand kit (SABiosciences) for qPCR. Samples were mixed with the RT 2 SYBR Green master mix (HotStart DNA Taq Polymerase, SABiosciences) and validated primers for key synaptic plasticity transcripts (RT 2 Profiler Kit, SABiosciences), before loading as technical duplicates for qPCR on a LightCycler 480 (Roche). C T values for tissue were normalized to four common reference genes as recommended by manufacturer. The Δ Δ C T method was used to provide gene expression values 51 . For whole-genome microarrays, gene expression for annotated genes was normalized and analysed using R package 3.1.2/Bioconductor, and two-way hierarchical clustering was performed using a correlation similarity metric distance. Whole-genome microarray data can be obtained using accession numbers E-MTAB-4087 or GSE75416 at ArrayExpress or GEO, respectively. Gene Ontology-based activation analysis was performed on significantly changed annotated genes with Ingenuity Pathway Analysis suite's (Qiagen) Comparison Analysis tool to compare predicted pathway activation states across treatments using networks of changed genes and literature-based functional information. The software integrates gene changes with functional annotation information to predict an activation related to the degree and direction of gene changes in that category. Statistics. Two-group comparisons were made using two-tailed, unpaired Student's t-test. For comparisons of more than two groups, one-way ANOVA followed by Tukey's post-hoc test was used. For comparisons of multiple factors (for example, time × treatment), two-way ANOVA was used before post-hoc testing. Repeatedmeasures two-way ANOVA with Bonferroni's post-hoc test was used for trial/ day × treatment comparisons with repeated observations. Numbers of mice were estimated to be sufficient to detect statistically meaningful differences of at least 20% between or among groups using standard power calculations with α = 0.05 and power of 0.8 on the basis of pilot or similar experiments. Homogeneity of variance was assessed, and appropriate corrections were made if necessary. All experiments were performed in a randomized and blinded fashion. Data were analysed statistically using GraphPad Prism 6.0, the R 3.1.2 package for Extended Data Fig. 1 and Fig. 1b, c , and SAM 3.0 for protein microarrays. The value of α was 0.05, and data are expressed as mean ± s.e.m. * P < 0.05; * * P < 0.01; * * * P < 0.001; * * * * P < 0.0001. Data availability. Source Data are provided or are available from the corresponding author upon reasonable request.
